ORIENTBIO Inc. Logo

ORIENTBIO Inc.

Provides animal models & technical services for preclinical R&D to pharma & research institutions.

002630 | KO

Overview

Corporate Details

ISIN(s):
KR7002630002
LEI:
Country:
South Korea
Address:
경기 성남시 중원구 상대원동 143-1, 성남시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ORIENTBIO Inc. is a biotechnology company specializing in the production and distribution of laboratory animal models for preclinical research. The company supplies a range of species, including mice and rats, to pharmaceutical companies, universities, and other research institutions. In addition to its core offering of animal models, ORIENTBIO provides related technical services such as genetic testing and molecular biological analysis to support life sciences research and development. The company operates AAALAC-accredited facilities, underscoring its commitment to high standards of animal welfare and care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 00:00
Quarterly Report
분기보고서 (2025.06)
Korean 882.1 KB
2025-06-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.4 KB
2025-06-19 00:00
Audit Report / Information
감사보고서제출
Korean 11.2 KB
2025-06-19 00:00
Annual Report
사업보고서 (2025.03)
Korean 1.3 MB
2025-06-19 00:00
Earnings Release
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 19.8 KB
2025-06-13 00:00
Audit Report / Information
[기재정정]감사보고서제출
Korean 29.5 KB
2025-06-13 00:00
Audit Report / Information
[기재정정]사업보고서 (2019.03)
Korean 463.2 KB
2025-06-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 128.0 KB
2025-06-12 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 7.3 KB
2025-05-13 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 11.5 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 3.9 KB
2025-02-14 00:00
Quarterly Report
분기보고서 (2024.12)
Korean 905.3 KB
2025-01-10 00:00
Regulatory News Service
조회공시요구(현저한시황변동)에대한답변(중요공시대상없음)
Korean 5.4 KB
2024-12-11 00:00
Regulatory News Service
조회공시요구(현저한시황변동)에대한답변(미확정)
Korean 6.6 KB
2024-12-11 00:00
Regulatory News Service
[기재정정]조회공시요구(현저한시황변동)에대한답변(미확정)
Korean 9.7 KB

Automate Your Workflow. Get a real-time feed of all ORIENTBIO Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ORIENTBIO Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ORIENTBIO Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
Developing a CIZ1B biomarker blood test for the early detection of lung cancer.
United Kingdom
CIZ
Clear Channel Outdoor Holdings, Inc. Logo
An OOH ad platform connecting brands to consumers via digital billboards and data analytics.
United States of America
CCO
CODEXIS, INC. Logo
Engineering high-performance enzymes for pharma, diagnostics, and life science manufacturing.
United States of America
CDXS
Cogent Biosciences, Inc. Logo
Developing precision small molecule therapies for cancers, autoimmune, and rare diseases.
United States of America
COGT
COMPASS Pathways plc Logo
Developing psilocybin therapies for severe mental health challenges like TRD and PTSD.
United States of America
CMPS
COMSCORE, INC. Logo
Cross-platform audience measurement and media analytics for advertisers, publishers, and agencies.
United States of America
SCOR
COPRO-HOLDINGS. Co., Ltd. Logo
Dispatches technical personnel to Japan's construction & plant industries.
Japan
7059
Corbus Pharmaceuticals Holdings, Inc. Logo
Clinical-stage oncology company developing targeted therapies like ADCs for cancer and obesity.
United States of America
CRBP
Corvus Pharmaceuticals, Inc. Logo
Develops novel, targeted therapies for immune diseases and cancer.
United States of America
CRVS
Coya Therapeutics, Inc. Logo
Developing Treg-modulating therapies for neurodegenerative and autoimmune diseases.
United States of America
COYA

Talk to a Data Expert

Have a question? We'll get back to you promptly.